A detailed history of Financial Perspectives, Inc transactions in Surmodics Inc stock. As of the latest transaction made, Financial Perspectives, Inc holds 6,014 shares of SRDX stock, worth $250,543. This represents 0.07% of its overall portfolio holdings.

Number of Shares
6,014
Previous 6,014 -0.0%
Holding current value
$250,543
Previous $219 Million 19.28%
% of portfolio
0.07%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 09, 2024

SELL
$43.21 - $57.6 $219,938 - $293,184
-5,090 Reduced 45.84%
6,014 $290 Million
Q3 2021

Jan 09, 2024

SELL
$52.8 - $60.32 $161,040 - $183,976
-3,050 Reduced 21.55%
11,104 $617 Million
Q2 2021

Jan 09, 2024

SELL
$51.29 - $59.15 $40 Million - $46.1 Million
-779,461 Reduced 98.22%
14,154 $768 Million
Q1 2021

Jan 09, 2024

BUY
$42.18 - $56.07 $32.9 Million - $43.7 Million
779,461 Added 5507.0%
793,615 $14.2 Million
Q4 2019

Jan 09, 2024

BUY
$39.01 - $47.51 $552,147 - $672,456
14,154 New
14,154 $586 Million

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $583M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Financial Perspectives, Inc Portfolio

Follow Financial Perspectives, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Perspectives, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Perspectives, Inc with notifications on news.